West Sacramento, California, United States United States
  • Overview
  • Team
  • Documents
Company description
Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders.
Our research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, we are advancing our goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation.

Our service unit provides biomarker discovery and biological consultation services for advancing drug development with our pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services.

Business model